Assessment of the use of spironolactone on the endothelial glycocalyx in high blood pressure

Phase 2

Withdrawn

• Conditions: Hypertension; Cardiovascular - Hypertension

• Registration Number: ACTRN12616000933459
• Lead Sponsor: Department of Renal Medicine, Box Hill Hospital

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2016-07-13
• Last Update Posted: 13 January 2020

Recruitment & Eligibility

• Status: Withdrawn
• Sex: All
• Target Recruitment: 30

Inclusion Criteria

Hypertension on 24-hr ambulatory blood pressure monitoring (>140/90mmHg)
and/or hypertensive event e.g. stroke
Microalbuminuria (spot urine ACR > 3 mg/mmol)

Exclusion Criteria

Malignancy, pregnancy, inability to consent, known haematological disorders, eGFR <60

Study & Design

• Study Type: Interventional
• Study Design: Not specified